MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Downloaded by: Stockholm University Library 130.237.165.40 - 11/28/2018 9:46:40 PM
Downloaded by: Stockholm University Library 130.237.165.40 - 11/28/2018 9:46:40 PM
Downloaded by: Stockholm University Library 130.237.165.40 - 11/28/2018 9:46:40 PM
Downloaded by: Stockholm University Library 130.237.165.40 - 11/28/2018 9:46:40 PM
Downloaded by: Stockholm University Library 130.237.165.40 - 11/28/2018 9:46:40 PM
Suggest Documents
Recurrent malignant gliomas.
Preliminary results of interstitial 192Ir brachytherapy for malignant gliomas.
Salvage radiosurgery for selected patients with recurrent malignant gliomas.
Brachytherapy for recurrent malignant tumours of the parotid gland.
Disease progression patterns of bevacizumab responders with recurrent malignant gliomas.
Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
Cellular immunotherapy for malignant gliomas.
Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.
Radiotherapy and brachytherapy for recurrent colorectal cancer.
Recurrent hemangiopericytoma and brachytherapy.
Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy.
Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas.
Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series.
Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.
Fotemustine: a third-generation nitrosourea for the treatment of recurrent malignant gliomas.
Salvage brachytherapy for recurrent prostate cancer.
[Chemotherapy in malignant gliomas].
Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
II study.
Adhesion molecules and malignant gliomas: implications for tumorigenesis.
Tumor metabolism of malignant gliomas.
Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy.
Ephs and Ephrins in malignant gliomas.
Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.
Brachytherapy for malignant recurrent and untreated gliomas.
Twelve consecutive patients with recurrent malignant glioma were treated with brachytherapy. Thereafter, a prospective randomized study involving 35 p...
441KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Recurrent malignant gliomas.
Preliminary results of interstitial 192Ir brachytherapy for malignant gliomas.
Salvage radiosurgery for selected patients with recurrent malignant gliomas.
Brachytherapy for recurrent malignant tumours of the parotid gland.
Disease progression patterns of bevacizumab responders with recurrent malignant gliomas.
Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
Cellular immunotherapy for malignant gliomas.
Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.
Radiotherapy and brachytherapy for recurrent colorectal cancer.
Recurrent hemangiopericytoma and brachytherapy.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms